Global Diabetic Macular Edema Epidemiology Forecast to 2030 - Understand the Magnitude of DME Population by its Severity - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Diabetic Macular Edema (DME) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the disease, historical and forecasted DME epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The DME epidemiology division provides the insights about historical and current DME patient pool and forecasted trend for each seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In 2020, the overall prevalent cases of DME accessed to be around 1,862,529 in the 7MM, which are expected to grow during the forecast period, i.e., 2021-2030.

The disease epidemiology covered in the report provides historical as well as forecasted DME epidemiology [segmented as Total Prevalent cases of DME, Total Diagnosed Prevalent cases of DME, Gender-specific Diagnosed Prevalent Cases of DME, Age-specific Diagnosed Prevalent Cases of DME, Subgroups-Specific Diagnosed Prevalent Cases of DME and Treated cases of DME] in the 7MM, covering the United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2021 to 2030.

Country Wise- DME Epidemiology

• In the United States, the total number of prevalent cases of DME were 1,026,346 in 2020 which are expected to increase during the forecast period, i.e., 2021-2030.
• In 2020, the total prevalent cases of DME were 641,864 in EU-5, which are projected to increased during the forecast period, i.e., 2021-2030.
• In Japan, the total number of prevalent cases of DME were 194,319 in 2020 which are expected to grow during the forecast period, i.e., 2021-2030.
• Findings from various secondary studies suggest that DME affects more males as compared to females, and is more prevalent in elderly population. In the 7MM, the gender-specific diagnosed cases of DME were 486,120 for males and 352,018 for females, in 2020. In the 7MM, the age-specific diagnosed prevalent cases of DME were 120,436, 363,767 and 353,935 for the age-groups 18-44, 45-64 and ?75 year, in 2020.
• In 2020, 193,979 non-central involved cases of DME and 267,876 central-involved DME cases were observed in the United States.

Scope of the Report

• The DME report covers a detailed overview explaining its causes, symptoms, and pathophysiology, diagnosis, and treatment patterns.
• The DME Report and Model provide an overview of the risk factors and global trends of DME in the seven major markets (7MM: United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of DME in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of DME.
• The report provides the segmentation of the DME epidemiology by total prevalent cases in the 7MM.
• The report provides the segmentation of the DME epidemiology by diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the DME epidemiology by gender-specific diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the DME epidemiology by age-specific diagnosed prevalent cases in the 7MM.
• The report provides the segmentation of the DME epidemiology by subgroups-specific diagnosed prevalent cases of DME in the 7MM.
• The report provides the segmentation of the DME epidemiology by treated cases of DME in the 7MM.

Reasons to Buy

The DME Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global DME market
• Quantify patient populations in the global DME market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for DME therapeutics in each of the markets covered
• Understand the magnitude of DME population by its severity
• The DME epidemiology report and model were written and developed by Masters and PhD level epidemiologists
• The DME Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 10-year forecast period using reputable sources

For more information about this report visit https://www.researchandmarkets.com/r/qdq8q